Programmed intermittent bolus infusion versus continuous infusion of 0.2% ropivacaine after ultrasound-guided continuous interscalene brachial plexus block in arthroscopic shoulder surgery
Not Applicable
Completed
- Conditions
- Diseases of the musculoskeletal system and connective tissue
- Registration Number
- KCT0005197
- Lead Sponsor
- Pusan National University Yangsan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
American Society of Anesthesiology physical status I-III patients scheduled for arthroscopic shoulder surgery
Exclusion Criteria
Patients who lack the ability to understand or perform the test in this study, patients with deficiency of blood clotting, patients with brachial plexus lesions, those with neurological defects at the treatment site, allergic reactions to ropivacaine in previous surgery or procedures, and pregnant women are excluded.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method